Matthew Walter
Washington University in St. Louis
H-index: 52
North America-United States
Top articles of Matthew Walter
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells | Cell Stress and Chaperones | Christopher Butler Morgan Dunmire Jaebok Choi Gabor Szalai Anissa Johnson | 2024/4/1 |
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk | Clinical Cancer Research | Duc Tran J Scott Beeler Jie Liu Brian Wiley Irenaeus CC Chan | 2024/3/26 |
R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts | Cancer Research | Zhiyan Silvia Liu Sayantani Sinha Maxwell Bannister Axia Song Erica Arriaga-Gomez | 2024/2/15 |
GEOGRAPHICAL AND SOCIOECONOMIC BARRIERS TO CARE FOR MYELODYSPLASTIC SYNDROMES | Leukemia Research | A Afzal M Fiala M Jacoby M Walter | 2023/5/1 |
Genomic landscape of TP53-mutated myeloid malignancies | Blood Advances | Haley J Abel Karolyn A Oetjen Christopher A Miller Sai M Ramakrishnan Ryan B Day | 2023/8/22 |
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS–AN … | Leukemia Research | T Silzle A Taylor T De Witte L Malcovati P Fenaux | 2021/9/1 |
Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm | Blood | J Scott Beeler Duc Tran Jie Liu Zilan Xin Brian Wiley | 2023/11/28 |
Topic: AS03-Health Economics & Outcome Research/AS03c-Efficacy outcome measures: STATINS IMPROVE OVERALL-AND LEUKEMIA FREE-SURVIVAL FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES … | Leukemia Research | V Santini R Bejar C Belli R Buckstein M Campelo | 2023/5/1 |
Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia | Blood Advances | Amber Afzal Mark A Fiala Meagan A Jacoby Matthew J Walter | 2023/8/8 |
Genetic Determinants of Clonal Hematopoiesis and Progression to Hematologic Malignancies in 479,117 Individuals | Blood | Jie Liu Duc Tran Irenaeus CC Chan Brian Wiley Caroline Watson | 2023/11/28 |
Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasms | Leukemia | Eileen Wedge Ulvi Ahmadov Thomas B Hansen Zongliang Gao Morten Tulstrup | 2023/5 |
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions | Blood Advances | Amy E DeZern Johannes B Goll R Coleman Lindsley Rafael Bejar Steffanie H Wilson | 2023/7/25 |
Reduced Subclone Diversity in Clonal Cytopenia of Undetermined Significance Compared to Myelodysplastic Syndrome | Blood | Monique Chavez Sridhar N Srivatsan Christopher A Miller Andrew J Menssen Ajay Khanna | 2023/11/28 |
PARP inhibitors preferentially sensitize splicing factor mutant myeloid neoplasms | Cancer Research | Dang Hai Nguyen Sayantani Sinha Zhiyan Silvia Liu Maxwell Henry Bannister Erica Arriaga-Gomez | 2023/4/4 |
A functional link between lariat debranching enzyme and the intron-binding complex is defective in non-photosensitive trichothiodystrophy | Molecular cell | Brittany A Townley Luke Buerer Ning Tsao Albino Bacolla Fadhel Mansoori | 2023/7/6 |
Correlation between Peripheral Blood and Bone Marrow Somatic Mutations Among Patients with Suspected or Established Myelodysplastic Syndromes from the National MDS Study | Blood | Amy E DeZern Johannes Goll Travis L Jensen Sridhar N Srivatsan Nancy K Gillis | 2023/11/28 |
Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation | JCI insight | Laneshia K Tague Karolyn A Oetjen Anirudh Mahadev Matthew J Walter Hephzibah Anthony | 2023/4/4 |
Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: SURFACE EPITOPE AND TRANSCRIPTOME ANALYSIS OF BONE MARROW IN MYELODYSPLASTIC SYNDROME (MDS) USING CITE-SEQ | Leukemia Research | R Kodgule K Oetjen J Ponce J Foltz J Robinson | 2023/5/1 |
Progressive, edematous plaques, mild pancytopenia, and inflammation | JAAD Case Reports | Leigh A Compton Heather A Jones Connor A Vinyard Yi-Shan Lee Matthew J Walter | 2023/12/1 |
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation | Transplantation and Cellular Therapy | Ziheng Xu Jaebok Choi Matthew Cooper Jeffrey King Mark A Fiala | 2023/11/1 |
